Marijuana and cannabinoid regulation of brain reward circuits

British Journal of Pharmacology

Volumn 143, Issue 2, 2004, Pages 227-234

  Lupica, Carl R ^a   Riegel, Arthur C ^a   Hoffman, Alexander F ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Conditioned place preference; Dopamine; Drug abuse; Intracranial self stimulation; Long term depression; Nucleus accumbens; Plasticity; Self administration; Tolerance; Ventral tegmental area

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABIS; DRONABINOL; PSYCHOTROPIC AGENT;

BRAIN FUNCTION; BRAIN REGION; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; HUMAN; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REINFORCEMENT; REWARD; SHORT SURVEY; STIMULUS; SYNAPTIC TRANSMISSION; SYSTEMATIC REVIEW; TRANQUILIZING ACTIVITY; VENTRAL TEGMENTUM;

ANIMALS; BRAIN; CANNABINOIDS; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); REWARD; UNITED STATES;

EID: 4744351585     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705931     Document Type: Short Survey

References (82)

1. ALGER, B.E. (2002). Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog. Neurobiol., 68, 247-286.
2. BARDO, M.T. (1998). Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit. Rev. Neurobiol., 12, 37-67.
3. BIDAUT-RUSSELL, M., DEVANE, W.A. & HOWLETT, A.C. (1990). Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J. Neurochem., 55, 21-26.
4. BREIVOGEL, C.S., GRIFFIN, G., DI, M.V. & MARTIN, B.R. (2001). Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol., 60, 155-163.
5. CAMERON, D.L., WESSENDORF, M.W. & WILLIAMS, J.T. (1997). A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience, 77, 155-166.
6. CARLEZON, W.A.J. & WISE, R.A. (1996a). Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward. Psychopharmacology (Berl.), 128, 413-420.
7. CARLEZON, W.A.J. & WISE, R.A, (1996b). Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J. Neurosci., 16, 3112-3122.
8. CARR, D.B. & SESACK, S.R. (2000). GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse, 38, 114-123.
9. CHEER, J.F., MARSDEN, C.A., KENDALL, D.A. & MASON, R. (2000). Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study. Neuroscience, 99, 661-667.
10. CHEN, J., MARMUR, R., PULLES, A., PAREDES, W. & GARDNER, E.L. (1993). Ventral tegmental microinjection of delta 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient. Brain Res., 621, 65-70.
11. CHEN, J.P., PAREDES, W., LI, J., SMITH, D., LOWINSON, J. & GARDNER, E.L. (1990), Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology (Berl.), 102, 156-162.
12. CHIENG, B. & WILLIAMS, J.T. (1998), Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal. J. Neurosci., 18, 7033-7039.
13. DEADWYLER, S.A., HEYSER, C.J., MICHAELIS, R.C. & HAMPSON, R.E. (1990). The effects of delta-9-THC on mechanisms of learning and memory. NIDA Res. Monogr., 97, 79-93.
14. DIANA, M., MELIS, M. & GESSA, G.L. (1998). Increase in mesoprefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids. Eur. J. Neurosci., 10, 2825-2830.
15. DI CHIARA, G. & IMPERATO, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A., 85, 5274-5278.
16. 9-tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci. Lett., 226, 159-162.
17. FRENCH, E.D., DILLON, K. & WU, X.F. (1997). Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport, 8, 649-652.
18. FREUND, T.F., KATONA, I. & PIOMELLI, D. (2003). Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev., 83, 1017-1066.
19. GAONI, Y. & MECHOULAM, R. (1964). Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc., 86, 1646.
20. GARDNER, E.L. (2002). Addictive potential of cannabinoids: the underlying neurobiology. Chem. Phys. Lipids, 121, 267-290.
21. GARDNER, E.L. & LOWINSON, J.H. (1991). Marijuana's interaction with brain reward systems: update 1991. Pharmacol. Biochem. Behav., 40, 571-580.
22. GARDNER, E.L. & VOREL, S.R. (1998). Cannabinoid transmission and reward-related events. Neurobiol. Dis., 5, 502-533.
23. GERDEMAN, G.L., PARTRIDGE, J.G., LUPICA, C.R. & LOVINGER, D.M. (2003). It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci., 26, 184-192.
24. GERDEMAN, G.L., RONESI, J. & LOVINGER, D.M. (2002). Post-synaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci., 5, 446-451.
25. 1 receptors. Eur. J. Pharmacol., 341, 39-44.
26. GONON, F.G. (1988). Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience, 24, 19-28.
27. GREEN, B., KAVANAGH, D. & YOUNG, R. (2003). Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev., 22, 453-460.
28. HAJOS, N. & FREUND, T.F. (2002). Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology, 43, 503-510.
29. HAJOS, N., LEDENT, C. & FREUND, T.F. (2001). Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience, 106, 1-4.
30. HAMPSON, R.E. & DEADWYLER, S.A. (1999). Cannabinoids, hippocampal function and memory. Life Sci., 65, 715-723.
31. 1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J. Neurosci., 17, 5271-5280.
32. HEIMER, L., ZAHM, D.S., CHURCHILL, L., KALIVAS, P.W. & WOHLTMANN, C. (1991). Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience, 41, 89-125.
33. HENRY, D.J. & CHAVKIN, C. (1995). Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci. Lett., 186, 91-94.
34. HERKENHAM, M., LYNN, A.B., JOHNSON, M.R., MELVIN, L.S., DE COSTA, B.R. & RICE, K.C. (1991). Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci., 11, 563-583.
35. HERKENHAM, M., LYNN, A.B., LITTLE, M.D., JOHNSON, M.R., MELVIN, L.S., DE COSTA, B.R. & RICE, K.C. (1990). Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A., 87, 1932-1936.
36. HOFFMAN, A.F. & LUPICA, C.R. (2000). Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J. Neurosci., 20, 2470-2479.
37. HOFFMAN, A.F. & LUPICA, C.R. (2001). Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J. Neurophysiol., 85, 72-83.
38. HOFFMAN, A.F., OZ, M., CAULDER, T. & LUPICA, C.R. (2003a). Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. J. Neurosci., 23, 4815-4820.
39. HOFFMAN, A.F., RIEGEL, A.C. & LUPICA, C.R. (2003b). Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus. Eur. J. Neurosci., 18, 524-534.
40. HOHMANN, A.G. & HERKENHAM, M. (2000). Localization of cannabinoid CB1 receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse, 37, 71-80.
41. HUESTIS, M.A., GORELICK, D.A., HEISHMAN, S.J., PRESTON, K.L., NELSON, R.A., MOOLCHAN, E.T. & FRANK, R.A. (2001). Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch. Gen. Psychiatry, 58, 322-328.
42. JOHNSON, S.W. & NORTH, R.A. (1992). Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci., 12, 483-488.
43. JOHNSON, S.W., SEUTIN, V. & NORTH, R.A. (1992). Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump. Science, 258, 665-667.
44. KITAI, S.T., SHEPARD, P.D., CALLAWAY, J.C. & SCROGGS, R. (1999). Afferent modulation of dopamine neuron firing patterns. Curr. Opin. Neurobiol., 9, 690-697.
45. KOÓS, T. & TEPPER, J.M. (1999). Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat. Neurosci., 2, 467-472.
46. MANZONI, O.J. & BOCKAERT, J. (2001). Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens. Eur. J. Pharmacol., 412, R3-R5.
47. MARTIN, G., NIE, Z. & SIGGINS, G.R. (1997). μ-opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons. J. Neurosci., 17, 11-22.
48. MATO, S., CHEVALEYRE, V., ROBBE, D., PAZOS, A., CASTILLO, P.E. & MANZONI, O.J. (2004). A single in-vivo exposure to Delta9THC blocks endocannabinoid-mediated synaptic plasticity. Nat. Neurosci., 7, 585-586.
49. MATSUDA, L.A., BONNER, T.I. & LOLAIT, S.J. (1993). Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol., 327, 535-550.
50. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA (see comments). Nature, 346, 561-564.
51. MCBRIDE, W.J., MURPHY, J.M. & IKEMOTO, S. (1999). Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav. Brain Res., 101, 129-152.
52. MECHOULAM, R., FRIDE, E. & DI, M.V. (1998). Endocannabinoids. Eur. J. Pharmacol., 359, 1-18.
53. MELIS, M., PISTIS, M., PERRA, S., MUNTONI, A.L., PILLOLLA, G. & GESSA, G.L. (2004). Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J. Neurosci., 24, 53-62.
54. NG CHEONG TON, J.M., GERHARDT, G.A., FRIEDEMANN, M., ETGEN, A.M., ROSE, G.M., SHARPLESS, N.S. & GARDNER, E.L. (1988). The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study. Brain Res., 451, 59-68.
55. NICOLA, S.M. & MALENKA, R.C. (1998). Modulation of synaptic transmission by dopamine and norepinephrine in ventral but not dorsal striatum. J. Neurophysiol., 79, 1768-1776.
56. PERTWEE, R.G. (1997). Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther., 74, 129-180.
57. PLENZ, D. (2003). When inhibition goes incognito: feedback interaction between spiny projection neurons in striatal function. Trends Neurosci., 26, 436-443.
58. B-mediated synaptic currents in midbrain dopamine neurons. Soc. Neurosci. Abstr., 33 (abstract no. 462.6).
59. RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G. & CAPUT, D. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240-244.
60. ROBBE, D., ALONSO, G., DUCHAMP, F., BOCKAERT, J. & MANZONI, O.J. (2001). Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci., 21, 109-116.
61. ROBBE, D., KOPF, M., REMAURY, A., BOCKAERT, J. & MANZONI, O.J. (2002). Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A., 99, 8384-8388.
62. SAAL, D., DONG, Y., BONCI, A. & MALENKA, R.C. (2003). Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron, 37, 577-582.
63. SCHLICKER, E. & KATHMANN, M. (2001). Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci., 22, 565-572.
64. STEFFENSEN, S.C., SVINGOS, A.L., PICKEL, V.M. & HENRIKSEN, S.J. (1998). Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J. Neurosci., 18, 8003-8015.
65. B receptors originate from discrete afferent neurons. Neurosci. Lett., 134, 207-211.
66. SULLIVAN, J.M. (2000). Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn. Mem., 7, 132-139.
67. SZABO, B., SIEMES, S. & WALLMICHRATH, I. (2002). Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur. J. Neurosci., 15, 2057-2061.
68. TANDA, G. & GOLDBERG, S.R. (2003). Cannabinoids: reward, dependence, and underlying neurochemical mechanisms - a review of recent preclinical data. Psychopharmacology (Berl.), 169, 115-134.
69. TANDA, G., MUNZAR, P. & GOLDBERG, S.R. (2000). Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat. Neurosci., 3, 1073-1074.
70. TANDA, G., PONTIERI, F.E. & DI CHIARA, G. (1997). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common μ1 opioid receptor mechanism. Science, 276, 2048-2050.
71. THOMAS, M.J., BEURRIER, C., BONCI, A. & MALENKA, R.C. (2001). Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat. Neurosci., 4, 1217-1223.
72. TWITCHELL, W., BROWN, S. & MACKIE, K. (1997). Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol., 78, 43-50.
73. VAN BOCKSTAELE, E.J. & PICKEL, V.M. (1995). GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain, Brain Res., 682, 215-221.
74. WALAAS, I. & FONNUM, F. (1980). Biochemical evidence for gamma-aminobutyrate containing fibres from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat. Neuroscience, 5, 63-72.
75. WILSON, R.I. & NICOLL, R.A. (2001). Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature, 410, 588-592.
76. WILSON, R.I. & NICOLL, R.A. (2002). Endocannabinoid signaling in the brain. Science, 296, 678-682.
77. WISE, R.A. (1996). Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci., 19, 319-340.
78. WISE, R.A. & BOZARTH, M.A. (1984). Brain reward circuitry: four circuit elements 'wired' in apparent series. Brain Res. Bull., 12, 203-208.
79. WISE, R.A. & BOZARTH, M.A. (1985). Brain mechanisms of drug reward and euphoria. Psychiatr. Med., 3, 445-460.
80. WISE, R.A. & BOZARTH, M.A. (1987). A psychomotor stimulant theory of addiction. Psychol. Rev., 94, 469-492.
81. WU, X. & FRENCH, E.D. (2000). Effects of chronic delta9-tetra- hydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment (in process citation). Neuropharmacology, 39, 391-398.
82. ZAHM, D.S. (2000). An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci. Biobehav. Rev., 24, 85-105.